Cargando…
Global Regulatory Guidelines for Vaccines
Because in the past vaccines were considered inherently safe, only limited nonclinical testing used to be required. However, from about 2003 more stringent nonclinical testing guidelines were introduced for novel vaccines (and, in some cases, marketed vaccines attempting registration in new markets)...
Autor principal: | Plitnick, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149671/ http://dx.doi.org/10.1016/B978-0-12-394810-6.00009-5 |
Ejemplares similares
-
Strategies for the Nonclinical Safety Assessment of Vaccines
por: Wolf, Jayanthi J., et al.
Publicado: (2012) -
Development of New Tuberculosis Vaccines: A Global Perspective on Regulatory Issues
por: Brennan, Michael J, et al.
Publicado: (2007) -
Global regulatory reforms to promote equitable vaccine access in the next pandemic
por: Mahoney, Richard, et al.
Publicado: (2023) -
US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer’s Disease: Implications for Global Drug Development
por: Morant, Anne Vinther, et al.
Publicado: (2020) -
Asthma guidelines: Global to local
por: FitzGerald, J. Mark
Publicado: (2009)